Leon E. Rosenberg
Chairman at Talon Therapeutics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Elizabeth Weatherman | F | 64 |
Talon Therapeutics, Inc.
 Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 11 years |
| Craig W. Carlson | M | 76 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 14 years |
| Thomas J. Tarlow | M | - |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 15 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mark J. Ahn | M | 61 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 4 years |
| Steven R. Deitcher | M | 59 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 6 years |
| Jie Chen | M | 43 |
Yale University
| 7 years |
| Robert Grote | M | - |
Princeton University
| 4 years |
| Matt Little | M | - |
Princeton University
| 4 years |
| Gabriel Tenorio | M | - |
Princeton University
| 5 years |
| Refet Soykan Gürkaynak | M | - |
Princeton University
| 4 years |
| Rich Scudellari | M | - |
Yale University
| 4 years |
| Louis Beryl | M | - |
Princeton University
| 4 years |
| Martin Leif Peter Fransson | M | 50 |
Princeton University
| 6 years |
| Hakan Kaya | M | - |
Princeton University
| 4 years |
| David Hsu | M | - |
Princeton University
| 6 years |
| Jessamine Fitzpatrick | F | - |
Yale University
| 3 years |
| Jeffrey A. Silverman | M | - |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | - |
| Ja-Chin Lee | M | 45 |
Princeton University
| 4 years |
| Claude Berrebi | M | - |
Princeton University
| 7 years |
| Wade Donald Pfau | M | - |
Princeton University
| 4 years |
| Peter S. Ringrose | M | 78 |
Bristol-Myers Squibb Pharmaceutical Research Institute
| 5 years |
| Kathryn Hall | F | 66 |
Princeton University
| 18 years |
| Robert Spiegel | M | 73 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 3 years |
| Paul Maier | M | 76 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | - |
| John P. Iparraguirre | M | 48 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | 5 years |
| Tyler Marshall Nielsen | M | - |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA. | - |
| Andrew Ferrer | M | 44 |
Talon Therapeutics, Inc.
Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.
Princeton University
| 7 years |
| James McQuade | M | - |
Princeton University
| 5 years |
| Rajiv Vinnakota | M | 53 |
Princeton University
| 5 years |
| Yoni Goldberg | M | - |
Princeton University
| 4 years |
| Clare McKee | F | - |
Princeton University
| 4 years |
| Gabrielle Jabre | F | - |
Princeton University
| 4 years |
| Jacquie Siegmund | F | - |
Princeton University
| 4 years |
| Eric Egleston | M | - |
Princeton University
| 3 years |
| Valerie Smith | F | 68 |
Princeton University
| 14 years |
| Ken Schwartz | M | - |
Princeton University
| 4 years |
| Mary Kate Davis | F | - |
Princeton University
| 4 years |
| Amanda Santillo | F | - |
Princeton University
| 4 years |
| Lindsay Monti | F | - |
Princeton University
| 4 years |
| Neil Ahlsten | M | - |
Princeton University
| 2 years |
| Carolyn C Warner | F | - |
Princeton University
| 2 years |
| Corrie Kavanaugh | F | - |
Princeton University
| 4 years |
| Audrey Lee | F | - |
Princeton University
| 6 years |
| Peter Iskaros | M | - |
Princeton University
| 4 years |
| Stella Ma | F | - |
Princeton University
| 4 years |
| Eugene Gokhvat | M | - |
Princeton University
| 4 years |
| Oleg Polyakov | M | - |
Princeton University
| 3 years |
| Pritha Ghosh | M | - |
Princeton University
| 4 years |
| Berg Andrew | M | - |
Princeton University
| 4 years |
| Edward Cong | M | - |
Princeton University
| 4 years |
| Smith Chad | M | - |
Princeton University
| 4 years |
| Brian Fishbein | M | - |
Princeton University
| 4 years |
| Christina Chang | M | - |
Princeton University
| 4 years |
| Evan Thorpe | M | - |
Princeton University
| 4 years |
| Carrington Akosa | M | - |
Princeton University
| 4 years |
| Caroline Bottinelli | F | - |
Princeton University
| 4 years |
| Noah Charles Bramlage | M | - |
Princeton University
| 4 years |
| Peter McCall | M | - |
Princeton University
| 4 years |
| Peter Muller | M | - |
Princeton University
| 4 years |
| Ali Kelley | F | - |
Princeton University
| 4 years |
| Catherine Casey Nanda | F | - |
Princeton University
| 4 years |
| Alicia Zeng | F | - |
Princeton University
| 4 years |
| Frank Fabozzi | M | 76 |
Princeton University
| 9 years |
| Daniela Torrebiarte | F | - |
Princeton University
| 4 years |
| Jeremy Johnson | M | - |
Princeton University
| 4 years |
| Max Hui | M | 50 |
Princeton University
| 1 years |
| Pete Tedesco | M | - |
Princeton University
| 4 years |
| Joung Park | M | - |
Princeton University
| 4 years |
| Robin T. Garner | F | - |
Yale University
| 4 years |
| Lori Fouché | F | 54 |
Princeton University
| 4 years |
| Andre Kurs | M | - |
Princeton University
| 4 years |
| Alex Thorn | M | - |
Princeton University
| 4 years |
| Brian Carthas | M | - |
Princeton University
| 4 years |
| Matt Peltz | M | 41 |
Yale University
| 4 years |
| Brian Christiansen | M | - |
Yale University
| 4 years |
| Joseph Edward Mack | M | - |
Yale University
| 4 years |
| Frank C. Atkins | M | - |
Yale University
| 2 years |
| William W. MacColl | M | - |
Princeton University
| 4 years |
| James W. Soldano | M | - |
Princeton University
| 4 years |
| Bernd Seizinger | M | 67 |
Bristol-Myers Squibb Pharmaceutical Research Institute
| 4 years |
| Robert J. Holuba | M | - |
Princeton University
| 4 years |
| Jeff Zhu | M | - |
Yale University
| 4 years |
| Ken Deeter | M | - |
Princeton University
| 4 years |
| Samy Jazaerli | M | - |
Princeton University
| 1 years |
| Maggie Louise Callahan | F | - |
Princeton University
| 4 years |
| Zhang Kevin | M | - |
Princeton University
| 4 years |
| Sims Lansing | M | - |
Princeton University
| 4 years |
| William Schaffer | M | - |
Princeton University
| 4 years |
| Leo Kang | M | - |
Princeton University
| 4 years |
| Raleigh G. Allison | M | - |
Princeton University
| 4 years |
| Justin Kan | M | - |
Yale University
| 4 years |
| Graham M. Radman | M | - |
Yale University
| 4 years |
| Tom O'Rourke | M | - |
Princeton University
| 4 years |
| Luciana Aranha Alves Barreto | F | - |
Princeton University
| 4 years |
| Eli Luberoff | M | - |
Yale University
| 4 years |
| Bryant Dieffenbacher | M | - |
Yale University
| 4 years |
| Li Han Sun | M | - |
Yale University
| 4 years |
| Ajay Kishore | M | - |
Yale University
| 4 years |
| Philip Uhde | M | 38 |
Yale University
| 4 years |
| Meg Nakamura | F | - |
Princeton University
| 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Leon E. Rosenberg
- Personal Network
